Vivo Ventures: 新闻

关于我们

我们的团队

我们的投资项目

联系我们

新闻

China Kanghui Holdings Announces Pricing of Initial Public Offering
Changzhou, China - August 10, 2010

FDA Approves Sagent Pharmaceuticals, Inc.'s Heparin Sodium Injection, USP
Schaumburg, IL - July 1, 2010

Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders
Malvern, PA – June 30, 2010

Dynavax Raises $44 Million Through Public Offering of Common Stock and Warrants
Berkeley, CA - April 13, 2010

Sagent Pharmaceuticals Raises $40 Million in Two Tranches of a Series B Financing
Schaumburg, IL - April 8, 2010

Merz to Acquire BioForm Medical
Frankfurt, Germany & San Mateo, CA - January 4, 2010

Lee's Pharmaceutical Signed a Subscription Agreement with Vivo Ventures Fund
Shatin, Hong Kong - August 12, 2009

AVANIR Announces Positive Phase III Study Results for Zenvia
Aliso Viejo, CA - August 11, 2009

Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
Palo Alto, CA - August 10, 2009

KangHui Medical Raises Series B-1 Extension Round
Palo Alto, CA - April 24, 2009

Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Palo Alto, CA - February 24, 2009

APT Pharmaceuticals Secures $32 Million in Series B Financing
Burlingame, CA - September 30, 2008

Sagent Completes $30 Million Series A Financing Extension
Schaumburg, IL - September 4, 2008

SpectraGenics Announces $30M in New Funding Changes Company Name to Tria Beauty
Pleasanton, CA - July 10, 2008

AVANIR to Raise $40.0 Million to Fund Zenvia Through Clinical Development and Regulatory Approval
Palo Alto, CA - March 27, 2008

Carbylan Announces $20 Million Series B Financing
Aliso Viejo, CA - Nov 26, 2007

Yaupon Therapeutics closes $14.5 million financing -- Series C financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases
Radnor, PA - Nov 19, 2007

BioForm Announces Pricing of Initial Public Offering
San Mateo, CA - Nov 07, 2007

Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
Palo Alto, CA - October 24, 2007 - Vivo Ventures

APT Pharmaceuticals Closes New $22 Million Funding Round
Burlingame, CA - October 4, 2007

Sagent Pharmaceuticals Inc. Completes $53M Series A Financing
Schaumburg, IL - September 27, 2007

Acura Pharmaceuticals, Inc. secures financing to fund pivotal Phase III clinical trial for lead Aversion® technology product candidate
Palatine, IL - August 20, 2007

Capnia names chairman, CEO
Palo Alto, CA - August 6, 2007

Biodel Inc. Announces Completion of Public Offering
DANBURY, CT - May 17, 2007

Vivo Ventures Announces the Closing of Vivo Ventures Fund VI, a $275M Life Science Venture Fund
Palo Alto, CA - May 7, 2007